Reactive-to-Proactive Process Monitoring in Pharmaceutical Waters

Meeting the evolving requirements of pharma waters with proactive process control

Program Overview

  • Cost and effort reduction based on ensuring, production of water with low total organic carbon (TOC) content
  • How sudden system upsets can be detected immediately and the length of time the upset is in place can be determined through trending data
  • How real-time TOC, Conductivity/Resistivity, temperature and microbial process information provides better transparency

This on demand webinar hosted by American Pharmaceutical Review covers the evolving requirements around pharmaceutical water monitoring, the need for more accurate proactive monitoring capabilities for better process control, and how to adapt these newer technologies while adhering to stringent regulations.

Better process control and transparency in pharma water process monitoring is necessary to provide quick risk assessment that can prevent undetected issues and production shutdowns. The ability to use continuous trending of water system data for measurements like TOC, conductivity and bioburden allows for focus on bioburden growth and biofilm formation prevention, which reduces cost and effort and ensures control of the water system for higher quality output.

In pharmaceutical water process monitoring, there is a need to change operating philosophy from reactive to proactive. This provides better transparency and increases the ability to better control water quality. Real time, continuous feedback on TOC ensures that TOC content of water remains low and can eliminate the struggle with biofilm formation and the risks it presents in pharma water quality.

The importance of true real time methods for not only TOC, but also conductivity and bioburden vs a "trap and read" method, eliminates delayed results and water waste. It can also reduce overall cost and effort but ensures control of the water system and higher quality output.

Who Should Attend

Microbiologists, Process Engineers, Pharmaceutical Water Owners and Quality Control as well as those working in Pharmaceutical Industries

Presenter

Jim Cannon

Jim Cannon

Head of OEM and Markets at Mettler-Toledo Thornton

After receiving a B.S. in Biology, Jim continued with graduate degrees in Microbiology and Biophysics, and an MBA in Marketing and International Management. Cannon has over 35 years of experience in the management, design and development of ultrapure water treatment and technology. This includes measuring differential conductivity and UV oxidation for the detection of TOC in UPW and the design and commercialization of electrodeionisation modules.
Cannon is currently involved in the standards and regulatory organizations for the Semiconductor, Photovoltaic and Pharmaceutical markets, including the facilities and liquids committee, Reclaim/Reuse/Recycle Task Force and the UPW task Force. He has also involved in the development and the commercialization of alternative online microbial detection technology. He is also serving as technical advisor to several Pharmacopeia organizations and active in ISPE and PDA groups.

I want to…
Need assistance?
Our team is here to achieve your goals! Speak with our experts.